Close

landmark

Pfizer and biontech confirm high efficacy and no serious safety concerns through up to six months following second dose in updated topline analysis of landmark Covid-19 vaccine study

Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and […]

Read More